ASP Isotopes (NASDAQ:ASPI) vs. Methanex (NASDAQ:MEOH) Financial Contrast

ASP Isotopes (NASDAQ:ASPIGet Free Report) and Methanex (NASDAQ:MEOHGet Free Report) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and valuation.

Institutional and Insider Ownership

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 73.5% of Methanex shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by insiders. Comparatively, 1.0% of Methanex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares ASP Isotopes and Methanex’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ASP Isotopes -734.14% -161.55% -73.67%
Methanex 2.21% 5.35% 2.03%

Analyst Recommendations

This is a breakdown of current ratings for ASP Isotopes and Methanex, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ASP Isotopes 1 0 2 0 2.33
Methanex 0 5 6 1 2.67

ASP Isotopes presently has a consensus target price of $13.00, indicating a potential upside of 139.41%. Methanex has a consensus target price of $59.20, indicating a potential downside of 1.94%. Given ASP Isotopes’ higher possible upside, equities research analysts clearly believe ASP Isotopes is more favorable than Methanex.

Volatility & Risk

ASP Isotopes has a beta of 3.59, indicating that its stock price is 259% more volatile than the S&P 500. Comparatively, Methanex has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500.

Earnings and Valuation

This table compares ASP Isotopes and Methanex”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ASP Isotopes $23.85 million 28.66 -$175.09 million ($2.14) -2.54
Methanex $3.59 billion 1.30 $79.88 million $1.13 53.42

Methanex has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Methanex, indicating that it is currently the more affordable of the two stocks.

Summary

Methanex beats ASP Isotopes on 11 of the 15 factors compared between the two stocks.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

About Methanex

(Get Free Report)

Methanex Corporation produces and supplies methanol in China, Europe, the United States, South America, South Korea, Canada, and Asia. The company also purchases methanol produced by others under methanol offtake contracts and on the spot market. In addition, it owns and leases storage and terminal facilities. The company owns and manages a fleet of approximately 30 ocean-going vessels. It serves chemical and petrochemical producers. Methanex Corporation was incorporated in 1968 and is headquartered in Vancouver, Canada.

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.